Overview

Leflunomide + Methotrexate in Rheumatoid Arthritis

Status:
Completed
Trial end date:
2004-08-01
Target enrollment:
Participant gender:
Summary
To determine the efficacy and safety of the combination of leflunomide and methotrexate for treating active rheumatoid arthritis (RA) in an open noncomparative multicenter trial.
Phase:
Phase 4
Details
Lead Sponsor:
Sanofi
Treatments:
Antirheumatic Agents
Leflunomide
Methotrexate